New Hampshire
New Hampshire has not enacted adult-use legalization. It operates a medical-only Therapeutic Cannabis Program under RSA Chapter 126-X, signed in July 2013 and administered by the Department of Health and Human Services; the first medical dispensary sales occurred in 2016. It is the only New England state without an adult-use market. The program is built on a capped, vertically integrated model: RSA 126-X:7 permits no more than four alternative treatment centers to hold registration certificates at one time. Three centers — GraniteLeaf Cannabis, Sanctuary, and Temescal Wellness — are registered and operational, each cultivating, manufacturing, and dispensing its own product under a single unitary license. They operate seven dispensary locations across the state. That works out to 2.13 operating cultivators per million residents and 0.5 operating dispensaries per 100,000 residents, against a population of 1,409,032. The registered-patient base has grown every year of the program, from 2,089 in calendar-year 2016 to 14,705 at the end of calendar-year 2024, reaching 16,838 by June 2025. New Hampshire imposes no tax of any kind on therapeutic cannabis and levies no general state sales tax. The Department of Health and Human Services publishes registry and demographic data but no aggregate dollar sales, so the dollar size of the market cannot be stated from primary public records.
Licensing & Market
New Hampshire issues a single unitary alternative treatment center registration that performs cultivation, manufacturing, and dispensing; there is no standalone cultivation-only or retail-only license, so vertical integration is required by design. RSA 126-X:7, III caps the program at no more than four alternative treatment centers. Three certificates have been issued — GraniteLeaf Cannabis, Sanctuary, and Temescal Wellness — and all three are operational, cultivating and dispensing. They run seven open dispensary locations: Chichester, Conway, Dover, Keene, Lebanon, Merrimack, and Plymouth. There are 2.13 operating alternative treatment centers per million residents and 0.5 operating dispensaries per 100,000 residents. The majority of an applicant's board members must be New Hampshire residents (RSA 126-X:7, IV(a)(4)); the statute sets no minimum prior-residency duration. New Hampshire has no municipal opt-in or opt-out framework: siting is controlled by the Department of Health and Human Services, and municipalities provide local zoning, health, and fire approvals but cannot ban a center. The application fee is a $3,000 nonrefundable submission fee under He-C 402.04, with a $20,000 selection fee and proof of $2 million in liability insurance required on selection (He-C 402.05). The state tracks product through BioTrack, identified through a secondary source rather than a primary Department contract. Whether a registration is transferable is not specified in statute.
| Field | Value | Source |
|---|---|---|
| Cultivator licenses awarded | 3 | [5] |
| Cultivator licenses operational | 3 | [6] |
| Cultivator activation rate | 100% | [7] |
| Operating cultivators per million | 2.13 | [8] |
| Retail licenses awarded | 7 | [9] |
| Retail licenses operational | 7 | [10] |
| Retail activation rate | 100% | [11] |
| Dispensaries per 100k | 0.5 | [12] |
| Vertical integration | required | [13] |
| License caps exist | Yes | [14] |
| Licenses transferable | Not available in the public record | — |
| Residency required | Yes | [15] |
| Residency duration (months) | Not available in the public record | — |
| Municipalities allowing | Not available in the public record | — |
| Municipalities total | Not available in the public record | — |
| Municipal opt-in rate | Not available in the public record | — |
| Track-and-trace system | BioTrack | [16] |
| Cultivator application fee | $3,000 | [17] |
| Cultivator annual fee | Not available in the public record | — |
| Retail application fee | Not available in the public record | — |
| Retail annual fee | Not available in the public record | — |
Consumer Rules
A qualifying patient may possess up to 2 ounces of usable cannabis and may obtain no more than 2 ounces during any 10-day period (RSA 126-X:2, I; RSA 126-X:8, XIII(b)). Home cultivation is not permitted for patients or caregivers — RSA 126-X:1 excludes patient and caregiver cultivation from therapeutic use, and only alternative treatment centers may grow cannabis. The 2-ounce per-10-day cap applies to total usable cannabis; statute sets no separate per-form limit for concentrates or edibles. RSA 126-X:1 defines usable cannabis broadly and RSA 126-X:3 permits vaporization; centers dispense flower, pre-rolls, vape products, concentrates, edibles, tinctures, and topicals, and no major mainstream product form is prohibited by the enabling statute, with manufactured-product and potency requirements set by departmental rule (He-C 402). Center-to-patient delivery is statutorily authorized (RSA 126-X:1; RSA 126-X:2); whether centers actively run home delivery is not confirmed in the primary record. The program has no on-site consumption category; consumption lounges are not authorized.
| Field | Value | Source |
|---|---|---|
| Home grow allowed | No | [20] |
| Home grow plant limit | Not available in the public record | — |
| Possession limit (oz) | 2 | [19] |
| Delivery legal | Yes | [18] |
| Delivery operational | Not available in the public record | — |
| Consumption lounges legal | No | [21] |
| Consumption lounges count | 0 | [22] |
| Purchase limit, flower (oz) | 2 | [23] |
| Purchase limit, concentrate (g) | Not available in the public record | — |
| Purchase limit, edibles (mg) | Not available in the public record | — |
| All product forms legal | Yes | [24] |
| Restricted product forms | RSA 126-X:1 defines 'usable cannabis' broadly ('dried leaves and flowers of the cannabis plant and any mixture or preparation thereof') and RSA 126-X:3 expressly permits vaporization; NH ATCs dispense flower, pre-rolls, vape/inhalation products, concentrates, edibles, tinctures, and topicals. No major mainstream product category is statutorily prohibited; specific manufactured-product and edible-potency requirements are set by departmental rule (He-C 402). | [25] |
Taxation
New Hampshire imposes no tax of any kind on therapeutic cannabis. RSA 126-X contains no tax provision, the state levies no general sales or use tax (New Hampshire Department of Revenue Administration), and municipalities have no authority to levy a local sales or cannabis tax. The total effective consumer tax rate on cannabis is 0 percent, and the state collects $0 in cannabis tax revenue — there is no excise tax, no sales tax, no local tax, and no adult-use market to tax. No cannabis tax has ever existed in New Hampshire to rise or fall, so the rate is unchanged since the program began.
| Field | Value | Source |
|---|---|---|
| Excise tax | Not available in the public record | — |
| Excise tax type | none | [26] |
| Sales tax | 0% | [27] |
| Wholesale tax | Not available in the public record | — |
| Potency tax exists | No | [28] |
| Potency tax, flower | Not available in the public record | — |
| Potency tax, concentrate | Not available in the public record | — |
| Potency tax, edibles | Not available in the public record | — |
| Local tax (max) | 0% | [29] |
| Local tax (typical) | 0% | [30] |
| Total effective rate | 0% | [31] |
| Medical tax exempt | Yes | [32] |
| Medical tax rate | 0% | [33] |
| Annual tax revenue | $0 | [34] |
| Tax revenue per capita | $0 | [35] |
| Tax changed since legalization | No | [36] |
| Tax direction | unchanged | [37] |
Operator Data
The Department of Health and Human Services publishes registry and demographic data for the Therapeutic Cannabis Program but no aggregate dollar sales figure, and because therapeutic cannabis is untaxed there is no tax-derived revenue proxy. An annual market dollar total, per-capita sales, and year-over-year growth therefore cannot be stated from primary public sources. New Hampshire publishes no wholesale or retail price index, and the alternative treatment centers are vertically integrated — each grows and sells its own product with no arm's-length wholesale market — so wholesale price levels and operator margins are not available in the public record. A secondary, operator-proximate source estimates retail flower at roughly $300 to $335 per ounce, but this is not an official published figure and is not used here. Three centers are operational against a statutory cap of four; no published series tracks a peak-versus-current center count, so license attrition cannot be computed.
| Field | Value | Source |
|---|---|---|
| Wholesale flower ($/lb) | Not available in the public record | — |
| Wholesale flower period | Not available in the public record | — |
| Wholesale trend | Not available in the public record | — |
| Wholesale price compression | Not available in the public record | — |
| Retail flower ($/oz) | Not available in the public record | — |
| Operator margin | Not available in the public record | — |
| Total market sales | Not available in the public record | — |
| Adult-use sales | Not available in the public record | — |
| Per-capita sales | Not available in the public record | [55] |
| YoY sales growth | Not available in the public record | — |
| License attrition (count) | Not available in the public record | — |
| License attrition | Not available in the public record | — |
| Peak cultivation licenses | Not available in the public record | — |
| Current cultivation licenses | 3 | [38] |
Consumer Data
New Hampshire's seven operating dispensary locations serve 0.5 dispensaries per 100,000 residents. The registered-patient base grew every year of the program, from 2,089 in calendar-year 2016 to 14,705 at the end of calendar-year 2024, reaching 16,838 by June 2025. The state publishes no aggregate dollar sales, so per-capita spending cannot be stated. No estimate of legal-market capture — the share of consumption met by the licensed program versus the unregulated market — is available in the public record; the figure is structurally difficult to establish for a small medical-only program bordered by four adult-use states.
| Field | Value | Source |
|---|---|---|
| Per-capita sales | Not available in the public record | [55] |
| Dispensaries per 100k | 0.5 | [12] |
| Legal market capture | Not available in the public record | — |
| Legal capture source | Not available in the public record | — |
| Retail price trend | Not available in the public record | — |
Equity Programs
New Hampshire has no social-equity program for cannabis. RSA 126-X establishes a capped alternative treatment center model with a patient-affordability application criterion but no equity license tier, set-aside, scoring preference, or dedicated equity fund, and the state has no adult-use program. The Department of Health and Human Services does not publish ownership-demographic figures for center operators. Expungement exists but is petition-based, not automatic: RSA 651:5-b (effective January 1, 2020) created a petition pathway to annul records for possession of three-quarters of an ounce or less predating September 16, 2017, and RSA 651:5-c (2024) extended petition-based annulment to cannabis possession records predating January 1, 2025. An automatic-annulment bill, HB 196, passed the House in 2025 but died in the Senate. The number of records annulled is not available in the public record.
| Field | Value | Source |
|---|---|---|
| Equity program exists | No | [39] |
| Equity program type | Not available in the public record | — |
| Equity licenses awarded | Not available in the public record | — |
| Equity licenses operational | Not available in the public record | — |
| Equity activation rate | Not available in the public record | — |
| Equity fund exists | No | [40] |
| Equity fund size | Not available in the public record | — |
| Equity fund disbursed | Not available in the public record | — |
| Equity fund disbursement rate | Not available in the public record | — |
| Minority ownership | Not available in the public record | — |
| Women ownership | Not available in the public record | — |
| Community reinvestment | Not available in the public record | — |
| Expungement exists | Yes | [41] |
| Expungement automatic | No | [42] |
| Expungements processed | Not available in the public record | — |
| Income cap for equity | Not available in the public record | — |
Enforcement
New Hampshire tracks regulated product through BioTrack, identified through a secondary source rather than a primary Department of Health and Human Services document. Beyond the tracking system, the state does not publish the operational metrics of enforcement as public figures: inspection counts, enforcement actions against centers, regulatory budget and staffing, mandatory testing analytes, per-batch testing cost, product recalls, and any fine schedule are not available in the public record. The Department's Therapeutic Cannabis Program and oversight-board reports that would carry these figures were not reachable for sourcing. Center enforcement under RSA 126-X:9 is primarily revocation-based rather than a published graduated fine schedule. This section is therefore largely NOT_AVAILABLE — not because enforcement does not occur, but because the regulator does not report these figures in a form that can be sourced for a public reference.
| Field | Value | Source |
|---|---|---|
| Track-and-trace system | BioTrack | [16] |
| Inspections per year | Not available in the public record | — |
| Enforcement actions (licensees) | Not available in the public record | — |
| Unlicensed-market enforcement actions | Not available in the public record | — |
| Regulatory budget | Not available in the public record | — |
| Regulatory staff | Not available in the public record | — |
| Mandatory testing analytes | Not available in the public record | — |
| Testing cost per batch | Not available in the public record | — |
| Product recalls per year | Not available in the public record | — |
| Fine schedule (min) | Not available in the public record | — |
| Fine schedule (max) | Not available in the public record | — |
Penalties & Criminal Law
New Hampshire has never enacted adult-use legalization; the net direction of its cannabis penalties since the medical program began in 2013 is lighter, and no cannabis penalty has been increased. HB 640, effective September 2017, decriminalized possession of three-quarters of an ounce or less to a $100 civil violation (RSA 318-B:2-c). Possession of more than three-quarters of an ounce is a misdemeanor carrying up to one year and a minimum fine of $350 for a first offense (RSA 318-B:26, II(c) and XIII); cannabis possession does not escalate to a felony at any weight. Unlicensed sale and manufacture are charged by aggregate weight under RSA 318-B:26, I, where sale or manufacture of any quantity is already a felony: less than 1 ounce carries up to 3 years and a $25,000 fine, 1 ounce to under 5 pounds up to 7 years and $100,000, and 5 pounds or more up to 20 years and $300,000 for a first offense, rising to 40 years and $500,000 for a subsequent offense. Home cultivation is treated as manufacture and is prohibited even for registered patients. New Hampshire sets no per se THC blood limit for impaired driving, prosecuting under an impairment standard (RSA 265-A:2). Expungement is petition-based, not automatic. Reported cannabis arrests fell from 2,851 in calendar-year 2018 to 791 in calendar-year 2024; these counts come from a secondary compilation of federal data that is an acknowledged undercount. The most recent available racial-disparity figure, from the ACLU of New Hampshire using 2020 arrest data, found Black residents 4.8 times more likely than white residents to be arrested for cannabis.
| Field | Value | Source |
|---|---|---|
| Max penalty, unlicensed cultivation | NH treats unlicensed cultivation as 'manufacture' of a controlled drug (RSA 318-B:2). Penalties scale by aggregate weight under RSA 318-B:26, I: less than 1 oz = felony, up to 3 years and $25,000 (first offense); 1 oz to under 5 lbs = felony, up to 7 years and $100,000; 5 lbs or more = felony, up to 20 years and $300,000 (up to 40 years and $500,000 for a subsequent offense). No personal/home cultivation is permitted, including for registered therapeutic-cannabis patients. | [43] |
| Max penalty, unlicensed sale | Unlicensed sale/manufacture/possession-with-intent under RSA 318-B:26, I scales by weight: less than 1 oz marijuana = felony, up to 3 years and $25,000 (first offense); 1 oz to under 5 lbs = up to 7 years and $100,000; 5 lbs or more = up to 20 years and $300,000 (first offense), rising to 40 years and $500,000 for a subsequent offense. | [44] |
| Felony threshold (grams) | 0 | [45] |
| Felony threshold type | sale | [46] |
| Penalty, possession over limit | Simple possession of more than 3/4 oz (21.3 g) of marijuana is a misdemeanor (max 1 year; minimum fine $350 first / $500 subsequent) under RSA 318-B:26, II(c) and XIII. Possession of 3/4 oz or less is a civil violation ($100 fine for first/second offense) under RSA 318-B:2-c (HB 640, eff. 2017). NH cannabis possession does not escalate to a felony at any weight; the felony tiers attach to sale/manufacture, not simple possession. | [47] |
| Penalty, public consumption | Not available in the public record | — |
| DUI per se limit (ng) | Not available in the public record | — |
| DUI zero tolerance | No | [48] |
| Penalties increased post-legalization | No | [49] |
| Penalty direction | lighter | [50] |
| Penalty direction details | New Hampshire has never enacted adult-use legalization; relative to its medical program (RSA 126-X, 2013) and decriminalization era, every material cannabis change has moved lighter. HB 640 (eff. Sept 2017) decriminalized possession of 3/4 oz or less from a misdemeanor to a $100 civil violation. RSA 651:5-b (eff. Jan 1, 2020) created a petition pathway to annul pre-2017 small-possession records, and RSA 651:5-c (2024) extended petition-based annulment to cannabis possession convictions/arrests predating Jan 1, 2025. No cannabis penalty has been increased. An automatic-annulment bill (HB 196, 2025) passed the House but died in the Senate. | [51] |
| Post-legalization arrests (annual) | 791 | [52] |
| Racial disparity ratio | 4.8 | [53] |
| Expungement exists | Yes | [41] |
| Expungement automatic | No | [42] |
Sources
- ↑ U.S. Census Bureau, Vintage 2024 Population Estimates (NST-EST2024-POP), State of New Hampshire https://www.census.gov/data/tables/time-series/demo/popest/2020s-state-total.html
- ↑ USPS / U.S. Census Bureau standard two-letter abbreviation for New Hampshire https://www.census.gov/library/reference/code-lists/ansi.html
- ↑ Dashboard compilation date 2026-06-07. Underlying vintages: RSA 126-X / RSA 318-B (current enrolled statute); NH DHHS TCP registry data (through June 2025 via press coverage); Census Vintage 2024 population; He-C 402 administrative rules https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ U.S. Census Bureau Vintage 2024 Population Estimates (NST-EST2024-POP), New Hampshire July 1, 2024 = 1,409,032 https://www2.census.gov/programs-surveys/popest/tables/2020-2024/state/totals/NST-EST2024-POP.xlsx
- ↑ RSA 126-X:7, III caps the program at no more than 4 alternative treatment centers (ATCs); three ATCs currently hold registration certificates — GraniteLeaf Cannabis (formerly Prime ATC), Sanctuary ATC (Sanctuary Medicinals), and Temescal Wellness. NH ATCs are vertically integrated and are the only legal cultivators. NH DHHS Therapeutic Cannabis Program ATC directory and DHHS ATC certificate news releases https://www.dhhs.nh.gov/programs-services/population-health/therapeutic-cannabis/alternative-treatment-centers
- ↑ All three registered ATCs (GraniteLeaf, Sanctuary, Temescal Wellness) are operational and cultivating/dispensing. NH DHHS Therapeutic Cannabis Program https://www.dhhs.nh.gov/programs-services/population-health/therapeutic-cannabis/alternative-treatment-centers
- ↑ CALC: 3 operational ATCs / 3 awarded registration certificates x 100 = 100%. (Statutory cap is 4; only 3 certificates have been issued.)
- ↑ CALC: 3 ATC operators / (1,409,032 / 1,000,000) = 2.13 per million https://www2.census.gov/programs-surveys/popest/tables/2020-2024/state/totals/NST-EST2024-POP.xlsx
- ↑ NH ATCs operate dispensary locations under their registration certificates (satellite dispensaries authorized by SB 388, 2018). Seven operating dispensary locations across the three ATCs: GraniteLeaf (Merrimack, Chichester), Sanctuary (Plymouth, Conway), Temescal Wellness (Dover, Lebanon, Keene). NH DHHS Therapeutic Cannabis Program ATC directory and DHHS dispensary certificate news releases https://www.dhhs.nh.gov/programs-services/population-health/therapeutic-cannabis/alternative-treatment-centers
- ↑ Seven dispensary locations are open and dispensing across the three ATCs (Chichester, Conway, Dover, Keene, Lebanon, Merrimack, Plymouth). NH DHHS Therapeutic Cannabis Program ATC directory https://www.dhhs.nh.gov/programs-services/population-health/therapeutic-cannabis/alternative-treatment-centers
- ↑ CALC: 7 operating dispensary locations / 7 authorized dispensary locations x 100 = 100%.
- ↑ CALC: 7 operating dispensary locations / (1,409,032 / 100,000) = 0.50 per 100K. NH DHHS ATC directory; Census Vintage 2024 population https://www.dhhs.nh.gov/programs-services/population-health/therapeutic-cannabis/alternative-treatment-centers
- ↑ RSA 126-X defines an alternative treatment center as a single entity that acquires, possesses, cultivates, manufactures, delivers, and dispenses cannabis; NH issues one unitary ATC registration that performs all functions (there is no standalone cultivation-only or retail-only license), so vertical integration is required by design https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 126-X:7, III: 'No more than 4 alternative treatment centers shall hold valid registration certificates at one time.' https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 126-X:7, IV(a)(4): 'The majority of board members shall be New Hampshire residents.' https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ [SECONDARY] NH Therapeutic Cannabis Program uses BioTrack seed-to-sale (NH program portal on biotrackthc.net); BioTrack lists New Hampshire among its government track-and-trace states. Primary DHHS/BioTrack contract documentation not directly fetchable; corroborated by OpenTHC NH wiki https://biotrack.com/legislation/new-hampshire/
- ↑ He-C 402.04(g)(1): a $3,000 nonrefundable Request for Applications (RFA) submission fee accompanies an ATC application. On selection, He-C 402.05(b) requires a further $20,000 selection fee and documentation of $2,000,000 liability insurance (He-C 402.05(c)(16)). The $3,000 RFA submission fee is NH's application fee for its unitary ATC license https://www.law.cornell.edu/regulations/new-hampshire/N-H-Admin-Code-SS-He-C-402.04
- ↑ RSA 126-X:1 defines an alternative treatment center as an entity that may 'deliver, transfer, supply ... and dispense cannabis ... to qualifying patients,' and RSA 126-X:2 protects ATC delivery to registered patients; ATC-to-patient delivery is therefore statutorily authorized https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 126-X:2, I(a): a qualifying patient may possess 'two ounces of usable cannabis'; RSA 126-X:8, XIII(b): a qualifying patient 'shall not obtain more than 2 ounces of usable cannabis ... during a 10-day period.' https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 126-X:1, XIII excludes 'cultivation by a designated caregiver or qualifying patient' from the definition of therapeutic use; only ATCs may cultivate. Home cultivation is not permitted https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 126-X authorizes dispensing of cannabis by ATCs to qualifying patients/caregivers and contains no provision for on-site consumption or social-use lounges; NH has no adult-use program https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ No on-site consumption category exists under RSA 126-X; count = 0 https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 126-X:8, XIII(b) sets a 2-ounce usable-cannabis dispensing cap per 10-day period (applies to total usable cannabis, not a separate per-form limit) https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 126-X:1 defines 'usable cannabis' broadly and RSA 126-X:3 permits vaporization; NH ATCs dispense flower, pre-rolls, vape products, concentrates, edibles, tinctures, and topicals, and no major mainstream product form is statutorily prohibited https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ Manufactured-product and edible-potency requirements are set by departmental rule (He-C 402); the enabling statute (RSA 126-X) prohibits no major product category https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ New Hampshire imposes no cannabis-specific excise tax; RSA 126-X contains no tax provision and NH has no adult-use market https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ New Hampshire levies no general state sales or use tax; therapeutic cannabis purchases are not subject to any state sales tax. NH Department of Revenue Administration https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ NH imposes no cannabis tax of any kind, including no potency-based tax https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ New Hampshire municipalities have no authority to levy a local sales tax or a local cannabis tax; the maximum local tax on cannabis is 0%. NH Department of Revenue Administration https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ No NH municipality levies any sales or cannabis tax (NH has no general sales tax) https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ CALC: NH levies no excise, sales, or local tax on therapeutic cannabis; total effective consumer tax rate = 0% https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ Therapeutic cannabis purchases by qualifying patients are not taxed in NH; RSA 126-X imposes no tax and NH has no general sales tax https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ 0% — NH imposes no tax on therapeutic cannabis https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ New Hampshire collects no cannabis tax revenue: RSA 126-X imposes no tax on therapeutic cannabis and NH has no adult-use market or general sales tax (NH Dept of Revenue Administration). Tax revenue = $0 https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ CALC: $0 cannabis tax revenue / 1,409,032 population = $0.00 per capita https://www.revenue.nh.gov/faq/does-new-hampshire-have-sales-tax
- ↑ NH has never taxed cannabis (medical program untaxed; no adult-use market), so no cannabis tax rate has changed https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ No cannabis tax has ever existed in NH to increase or decrease; unchanged https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ Three vertically integrated ATC operators (GraniteLeaf, Sanctuary, Temescal Wellness) hold registration certificates and cultivate cannabis. NH DHHS Therapeutic Cannabis Program https://www.dhhs.nh.gov/programs-services/population-health/therapeutic-cannabis/alternative-treatment-centers
- ↑ RSA 126-X establishes a capped, nonprofit-origin ATC model with a patient-affordability application criterion (RSA 126-X:7) but no social-equity license tier, set-aside, scoring preference, or equity fund; NH has no adult-use program https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ No dedicated cannabis equity fund exists in NH (no statutory equity program) https://gc.nh.gov/rsa/html/x/126-x/126-x-mrg.htm
- ↑ RSA 651:5-b (eff. Jan 1, 2020) created a petition pathway to annul records for possession of 3/4 oz or less predating Sept 16, 2017; RSA 651:5-c (2024) extended petition-based annulment to cannabis possession convictions/arrests predating Jan 1, 2025 https://gc.nh.gov/rsa/html/LXII/651/651-5-b.htm
- ↑ NH cannabis annulment is petition-based, not automatic (RSA 651:5-b and 651:5-c both require a petition); an automatic-annulment bill (HB 196, 2025) passed the House but died in the Senate https://gc.nh.gov/rsa/html/LXII/651/651-5-b.htm
- ↑ RSA 318-B:2 (prohibited acts, including manufacture) and RSA 318-B:26, I (penalties by aggregate weight: <1 oz up to 3 yrs/$25,000; 1 oz-<5 lbs up to 7 yrs/$100,000; 5 lbs+ up to 20 yrs/$300,000, first offense) https://gc.nh.gov/rsa/html/xxx/318-b/318-b-26.htm
- ↑ RSA 318-B:26, I — tiered felony penalties for sale/manufacture by weight, up to 20 years and $300,000 for 5 lbs+ (first offense) and up to 40 years and $500,000 for a subsequent offense https://gc.nh.gov/rsa/html/xxx/318-b/318-b-26.htm
- ↑ RSA 318-B:26 — unlicensed sale/manufacture of any quantity of marijuana is a felony (the lowest tier, <1 oz, is already a felony under I(d)), so the sale/cultivation felony threshold is effectively 0 g; simple possession of marijuana never reaches a felony at any weight (capped at misdemeanor under II(c)) https://gc.nh.gov/rsa/html/xxx/318-b/318-b-26.htm
- ↑ RSA 318-B:26, I — the felony threshold attaches to sale/manufacture (and possession-with-intent), not to simple possession https://gc.nh.gov/rsa/html/xxx/318-b/318-b-26.htm
- ↑ RSA 318-B:26, II(c) (possession of more than 3/4 oz = misdemeanor, max 1 year) and XIII (minimum fine $350 first / $500 subsequent); RSA 318-B:2-c (possession of 3/4 oz or less = $100 civil violation, HB 640, eff. 2017) https://gc.nh.gov/rsa/html/xxx/318-b/318-b-26.htm
- ↑ NH prosecutes drugged driving under an impairment standard (RSA 265-A:2) with no numeric per se THC threshold and no zero-tolerance provision; a positive THC test alone does not establish impairment https://gc.nh.gov/rsa/html/xxi/265-a/265-a-2.htm
- ↑ NH has never enacted adult-use legalization; no cannabis penalty has been increased in the medical/decriminalization era. Relevant changes (HB 640 decriminalization 2017; RSA 651:5-b/5-c annulment) moved lighter https://gc.nh.gov/rsa/html/xxx/318-b/318-b-2-c.htm
- ↑ Net direction of NH cannabis penalties since the medical program (2013) is lighter: 2017 decriminalization of 3/4 oz or less; 2020 and 2024 annulment pathways https://gc.nh.gov/rsa/html/xxx/318-b/318-b-2-c.htm
- ↑ HB 640 (eff. Sept 2017) decriminalized possession of 3/4 oz or less to a $100 civil violation; RSA 651:5-b (eff. Jan 1, 2020) created petition annulment for pre-2017 small-possession records; RSA 651:5-c (2024) extended petition-based annulment to cannabis possession records predating Jan 1, 2025. No cannabis penalty has been increased; an automatic-annulment bill (HB 196, 2025) passed the House but died in the Senate https://gc.nh.gov/rsa/html/LXII/651/651-5-b.htm
- ↑ [SECONDARY] NORML New Hampshire marijuana-arrest data compiling FBI UCR/NIBRS figures reported by NH agencies — 791 marijuana arrests in 2024 (715 possession + 76 sales); incomplete agency reporting makes this a likely undercount. Underlying primary: FBI Crime Data Explorer / NH State Police UCR program https://norml.org/marijuana/library/state-marijuana-arrests/new-hampshire-marijuana-arrests/
- ↑ [SECONDARY] ACLU of New Hampshire (April 2022), citing 2020 arrest data — Black people in NH were 4.8x more likely than white people to be arrested for marijuana (up from 2.6x in 2010); city extremes include Manchester 13.9x. Underlying primary: ACLU 'A Tale of Two Countries' analysis of FBI UCR data https://www.aclu-nh.org/en/press-releases
- ↑ see dispensary_per_100k
- ↑ NH DHHS does not publish aggregate dollar sales for the Therapeutic Cannabis Program, so per-capita sales cannot be computed from a primary source; field is null https://www.dhhs.nh.gov/programs-services/population-health/therapeutic-cannabis